Blue Heron is a modern hybrid-indica cultivar developed through the crossing of Blue Magoo and Oregon Huckleberry. Suited for both indoor and outdoor cultivation, this plant reaches maturity with a 60-day flowering period and is categorized as having moderate growing difficulty while offering a high yield. Its genetic influence remains significant within the industry, as evidenced by its notable offspring, which include Birds Of Paradise, Black Blue Magoo, Blue Heron #111 BX1, Blue Heron BX, Blue Magoo Bx2, Ocelot V2, Salmon River OG, and The Kiwi.

The chemical profile of Blue Heron is defined by a complex terpene hierarchy led by terpinolene, followed in descending order by myrcene, pinene, limonene, caryophyllene, ocimene, beta-pinene, humulene, linalool, bisabolol, guaiol, alpha-terpinene, nerolidol, and gamma-terpinene. This diverse composition results in a multifaceted sensory experience, where the dominance of terpinolene provides a distinct aromatic foundation that is nuanced by the presence of subsequent terpenes ranging from the earthy notes of myrcene to the floral and spice-tinged depths of linalool and caryophyllene.

As a THC-dominant cultivar, Blue Heron provides users with effects described as relaxed, calm, and focused. These characteristics make the strain a preferred choice for individuals seeking relief from pain, management of stress, or assistance with sleep. Through its combination of therapeutic potential and consistent growth habits, Blue Heron continues to function as a versatile genetic building block for subsequent hybridization projects.